Vital Signs as Predictor Factors of Intravenous Immunoglobulin Resistance in Patients With Kawasaki Disease

Clin Pediatr (Phila). 2018 Sep;57(10):1148-1153. doi: 10.1177/0009922818759320. Epub 2018 Feb 27.

Abstract

Kawasaki disease (KD) is the most common cause of acquired heart disease in children. Intravenous immunoglobulin (IVIG) may significantly lower the frequency of coronary artery complications. However, some patients do not respond to initial therapy and are at higher risk of developing coronary artery lesion. A retrospective analysis of data from 419 KD patients was performed. The patients were divided into IVIG responders (n = 318) and IVIG nonresponders (n = 101). Multivariate logistic regression analysis revealed neutrophil percentage, albumin, aspartate aminotransferase, heart rate, and body temperature were independent predictors of IVIG resistance. We generated a predictive scoring system by assigning 1 point for the presence of these parameters (neutrophil >80%, albumin <3.4 g/dL, aspartate aminotransferase >100 IU/L, heart rate >146 bpm, and body temperature >38.8°C). This scoring system had a sensitivity of 76.2% and specificity of 64.8%, and a positive predictive value of 40.1% and a negative predictive value of 89.4%. Vital signs may be helpful to detect KD patients with IVIG resistance.

Keywords: Kawasaki disease; immunoglobulin resistance; risk score; vital signs.

MeSH terms

  • Albumins / drug effects
  • Aspartate Aminotransferases / blood
  • Aspartate Aminotransferases / drug effects
  • Body Temperature / drug effects
  • Child
  • Child, Preschool
  • Female
  • Heart Rate / drug effects
  • Humans
  • Immunoglobulins, Intravenous / blood
  • Immunoglobulins, Intravenous / therapeutic use*
  • Infant
  • Male
  • Mucocutaneous Lymph Node Syndrome / blood
  • Mucocutaneous Lymph Node Syndrome / drug therapy*
  • Neutrophils / drug effects
  • Predictive Value of Tests
  • Reproducibility of Results
  • Retrospective Studies
  • Risk Factors
  • Sensitivity and Specificity
  • Tokyo
  • Treatment Failure
  • Vital Signs / drug effects*

Substances

  • Albumins
  • Immunoglobulins, Intravenous
  • Aspartate Aminotransferases